Delcath Systems (DCTH) Tops Q1 EPS by 7c May 7, 2026 08:07AM
Delcath Systems presents liver cancer treatment data at breast cancer congress May 7, 2026 07:01AM
Delcath CHEMOSAT therapy included in European uveal melanoma guidelines Apr 6, 2026 08:31AM
Delcath Systems (DCTH) PT Lowered to $18 at Craig-Hallum Feb 27, 2026 09:23AM
Delcath Systems (DCTH) PT Lowered to $27 at Clear Street Feb 26, 2026 01:15PM


Feb 26, 2026 11:54AM Delcath Systems (DCTH) PT Lowered to $19 at BTIG
Feb 26, 2026 08:12AM Delcath Systems (DCTH) Tops Q4 EPS by 3c
Jan 9, 2026 08:05AM Delcath Systems reports preliminary 2025 revenue of $85.2 million
Dec 3, 2025 04:11PM Delcath announces study showing 29-month survival for liver cancer treatment
Nov 13, 2025 08:32AM Delcath Systems reports study showing liver therapy benefits for melanoma
Nov 4, 2025 08:06AM Delcath Systems (DCTH) Tops Q3 EPS by 5c ; Offers Guidance
Oct 21, 2025 06:43AM Delcath Systems (DCTH) PT Lowered to $30 at H.C. Wainwright
Oct 20, 2025 07:52AM Delcath Systems reports Q3 revenue of $20.5 million, raises 2025 guidance
Oct 20, 2025 07:51AM Delcath Systems reports CHOPIN trial meets primary endpoint
Aug 6, 2025 08:10AM Delcath Systems (DCTH) Tops Q2 EPS by 4c ; Offers Guidance
May 23, 2025 06:36AM Delcath Systems (DCTH) PT Raised to $29 at H.C. Wainwright
May 22, 2025 10:57AM BTIG Reiterates Buy Rating on Delcath Systems (DCTH)
May 22, 2025 07:01AM Delcath Systems (DCTH) Issues Full Year 2025 Guidance
May 8, 2025 11:53AM Delcath Systems (DCTH) PT Raised to $26 at Clear Street
May 8, 2025 07:37AM Delcath Systems (DCTH) Tops Q1 EPS by 1c
Apr 28, 2025 08:31AM Delcath Systems (DCTH) Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
Mar 27, 2025 04:45PM Beta Bionics (BBNX) appoints Gerard Michel to Board
Mar 14, 2025 04:02PM Delcath Systems (DCTH) reports inducement grants
Mar 7, 2025 06:40AM Delcath Systems (DCTH) PT Raised to $24 at H.C. Wainwright
Mar 6, 2025 11:15AM Delcath Systems (DCTH) PT Raised to $22 at BTIG
Mar 6, 2025 08:00AM Delcath Systems (DCTH) Misses Q4 EPS by 11c
Jan 17, 2025 09:03AM Delcath Systems (DCTH) PT Raised to $21 at Craig-Hallum
Jan 13, 2025 08:13AM Delcath Systems (DCTH) Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
Dec 30, 2024 08:03AM Delcath Systems (DCTH) Announces Additional $16.3M in Funding From Series E and E1 Warrant Exercises
Dec 12, 2024 04:40PM Clear Street Starts Delcath Systems (DCTH) at Buy
Dec 2, 2024 08:32AM Delcath Systems (DCTH) Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
Nov 8, 2024 08:05AM Delcath Systems (DCTH) Tops Q3 EPS by 26c
Oct 18, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Delcath Systems (DCTH)
Oct 17, 2024 08:32AM Delcath Systems (DCTH) Reports Prelim Q3 Results
Aug 27, 2024 08:30AM Delcath Systems (DCTH) Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
Aug 26, 2024 04:02PM Delcath Systems (DCTH) Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
Aug 6, 2024 04:57AM Delcath Systems (DCTH) PT Raised to $20 at BTIG
Aug 5, 2024 04:02PM Delcath Systems (DCTH) Misses Q2 EPS by 12c
Jun 28, 2024 09:05AM Delcath Systems (DCTH) Files $100M Mixed Shelf